Skip to main content

5-Fluorouracil/Folinic Acid/Cisplatin-Combination and Simultaneous Accelerated Split-Course Radiotherapy in Advanced Head and Neck Cancer

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 244))

Summary

In advanced inoperable head and neck cancer radiotherapy alone is unsatisfying. Better results can be obtained by simultaneous 5-Fluorouracil/Cisplatin-chemotherapy and irradiation. The cytotoxicity of 5-Fluorouracil can be enhanced synergistically by adding Folinic Acid in excess.

In a clinical phase II trial 62 previously untreated patients suffering from unresectable AJCC-stage III (4 pts.) and IV (58 pts.) squamous cell carcinoma of the head and neck were treated with a simultaneous chemoradiotherapy consisting of high-dose Folinic Acid in addition to a 5-Fluorouracil/Cisplatin combination and of accelerated split-course radiotherapy.

As results, three pts. died from tumor arrosion bleeding during the treatment. Median follow up time of the surviving pts. is 27 + months (range 18–44 months). 48/62 pts. (77 %) achieved complete remission, 11/62 pts. (18 %) partial remission. Presently, 32 pts. (52 %) are without evidence of disease. Actuarial three years overall survival rate (Kaplan-Meier method) out of 62 pts. is 53 %. Actuarial disease free survival and local tumor control rates at three years are 58 % and 72 %.

Mucositis was severe but tolerable, bone marrow depression was moderate to marked. In conclusion, this combined simultaneous modality approach is highly effective in locally advanced head and neck cancer. It seems to provide superior survival and local control rates as compared to conventional radiotherapy or sequential chemo-radiotherapy or as compared to simultaneous 5-Fluorouracil/Cisplatin and non-fractionated radiotherapy. A comparative phase III study is required.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. Tannock, B. Cummings, V. Sorrenti, and the ENT group: Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck. Cancer Treat. Rep. 66: 1421–1424 (1982).

    Google Scholar 

  2. L.E. Kun, F.J. Toohill, P.Y. Holoye, J.A. Duncavage, R.W. Byhardt, T.W. Grossman, R.G. Hoffmann, J.D. Cox, and T. Malin: A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int. J. Radiat. Oncol. Biol. Phys. 12: 173–178 (1986).

    Article  CAS  Google Scholar 

  3. T.G. Wendt, M. Chucholowski, R.C. Hartenstein, R. Rohloff, and N. Willich: Sequential chemo-radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 12: 397–399 (1986).

    Article  CAS  Google Scholar 

  4. J.R. Bertino, D. Cooper, J. Chang, and L. Smaldone: Overview of chemotherapeutic agents with activity in cancer of the head and neck region, in “Head and neck cancer: Scientific perspectives in management ând strategies for cure”, J.R. Jacobs, J.D. Crissman, F.A. Valeriote, and M. Al-Sarraf, ed., Elsevier Amsterdam, pp. 159–174 (1987).

    Google Scholar 

  5. A. Weaver, S. Flemming, J. Kish, H. Vandenberg, J. Jacob, J. Crissman, and M. Al-Sarraf: Cis-platinum and 5-Fluorouracil as induction therapy for advanced head and neck cancer. Am. J. Surg. 144: 445–448 (1982).

    Article  CAS  Google Scholar 

  6. M. Al-Sarraf, J. Kish, J. Ensley, J. Jacobs, J. Kinzie, J. Crissman, and A. Weaver: Induction Cis-platinum and 5-Fluorouracil infusion before surgery and/or radiotherapy in patients with advanced head and neck cancer. Proc. Am. Ass. Cancer Res. 25: 196 (1984).

    Google Scholar 

  7. B. Ullman, M. Lee, D.W. Martin, jr: Increased L1210 sensitive FdUrd with LCV in-vitro. Proc. Nat. Acad. Sci. 75: 980 (1978).

    Article  CAS  Google Scholar 

  8. G.H. Heppner, and P. Calabresi: Increased antitumor activity with methotrexate prior to CLV 1 hr. prior to FUra in vivo-mammary tumor in C3H mice. Cancer Res. 37: 4580–4585 (1977).

    CAS  PubMed  Google Scholar 

  9. S. Waxman, H. Bruckner, and A. Wagles: Increased FUra cytotoxicity with LCV in-vitro. Proc. Am. Ass. Cancer Res. 19: 149 (1978).

    Google Scholar 

  10. S. Waxman, and H. Bruckner: The enhancement of 5-Fluorouracil antimetabolic activity by Leucovorin, Menadione and a-Tocopherol. Eur. J. Cancer Clin. Oncol. 18: 685–692 (1982).

    Article  CAS  Google Scholar 

  11. D. Machover, L. Schwarzenberg, E. Goldschmidt, J.M. Towani, B. Michalski, M. Hayat, T. Dorval, J.L. Misset, C. Jasmin R. Moral, and G. Mathé: Treatment of advanced colorectal and gastric Adenocarcinomas with 5-FU combined with high-dose Folinic Acid: a piolt study. Cancer Treat. Rep. 66: 1803–1807 (1982).

    CAS  Google Scholar 

  12. G. Marini, P. Marpicati, A. Zaniboni, G.C. Cervi, F. Gorni, and E. Simoncini: Treatment of advanced breast cancer with 5-Fluorouracil and high-dose Folinic Acid: Preliminary results. Chemioterapie 6: 135–138 (1985).

    Google Scholar 

  13. L.A. Szumiel, H.W. Nias: The effect of combined treatment with a platinum complex an ionizing radiation on chinese hamster ovary cells in vitro. Br. J. Cancer 33: 450–458 (1976).

    Article  CAS  Google Scholar 

  14. T.C.M. Lo, A.L. Wily, F.J. Ansfield, J.H. Brandenburg, H.L. Davis, F.E. Gollin, R.O. Johson, G. Ramirez, and H. Vermund: Combined radiation therapy and 5-Fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Radiology 126: 229–235 (1976).

    CAS  Google Scholar 

  15. J.E. Byfield, T.R. Sharp, S.S. Frankel, S.G. Tang, and F.B. Callipari: Phase I and II trial of five days infused 5-Fluorouracil and radiation in advanced cancer of the head and neck. J. Clin. Oncol. 2: 406–413 (1984).

    Article  CAS  Google Scholar 

  16. K.R. Trott, and J. Kummermehr: What is known about tumor proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother. Oncol. 3: 1–9 (1985).

    CAS  Google Scholar 

  17. E. Van der Schueren, W. Van den Bogaert, and K.K. Ang: Radiotherapy with multiple fractions per day:in “The biological basis of radiotherapy”, G.G. Steel, G.E. Adams, and M.J. Peckham, ed., Elsevier Amsterdam, pp. 195–210 (1983).

    Google Scholar 

  18. R.C. Hartenstein, T.G. Wendt, T.P.U. Wustrow, and K.R. Trott: Simultaneous twice-daily radiotherapy (RT) and Cisplatin (DDP)5-FU-chemotherapy with Folinic Acid (FA) enhancement in advanced squamous cell cancer (SCC) of the head and neck. Proc. Am. Soc. Clinc. Oncol. 5: 126 (1986).

    Google Scholar 

  19. T.G. Wendt, R.C. Hartenstein, T.P.U. Wustrow: Improved two years survival and local control rate in locally advanced squamous cell carcinoma (SCC) of the head and neck by simultaneous Chemo (CT)-Radiotherapy (RT): Progress report. Proc. Am. Soc. Clin. Oncol. 6: 125 (1987).

    Google Scholar 

  20. W.M. Mendenhall, J.T. Parsons, R.R. Million, J. Cassisi, J.W. Devine, and B.D. Greene: A favorable subset of AJCC stage IV squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 10: 1841–1843 (1984).

    Article  CAS  Google Scholar 

  21. WHO Handbook for reporting results of cancer treatment. WHO Offset Publication N° 48, Geneva (1979).

    Google Scholar 

  22. T.G. Wendt, T.P.U. Wustrow, R.C. Hartenstein, R. Rohloff, and K.R. Trott: Accelerated split-course radiotherapy and simultaneous cis-dichlorodiammine-platinum and 5-fluorouracil chemotherapy with folinic acid enhancement for unresectable carcinoma of the head and neck. Radiother. Oncol. 10: 277–284 (1987).

    Article  CAS  Google Scholar 

  23. C.C. Wang, H.D. Suit, P.H. Blitzer: Twice-a-day radiation therapy for supraglottic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 12: 3–7 (1986).

    Article  CAS  Google Scholar 

  24. D.J. Adelstein, V.M. Sharan, A.S. Earle, A.C. Shah, C. Vlastou, D.D. Haria, C. Damm, S.G. Carter, and J.D. Hines: Combined modality therapy (CMT) with simultaneous 5-fluorouracil (5-FU), cis-platinum (DDP)and radiation therapy (RT) in the treatment of squamous cell cancer of the head and neck. Proc.Am.Soc.Clin. Oncol. 5: 128 (1986).

    Google Scholar 

  25. S.G. Taylor, IV, A.K. Murthy, J.L. Showel, D.D. Caldarelli, J.C. Hutchinson, jr, L.D. Holinger, T. Kramer, and K. Kiel: Improved control in advanced head and neck cancer with simultaneous radiation and Cisplatin/5-FU chemotherapy. Cancer Treat. Rep. 69: 933–939 (1985)

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Hartenstein, R., Wendt, T.G., Kastenbauer, E.R. (1988). 5-Fluorouracil/Folinic Acid/Cisplatin-Combination and Simultaneous Accelerated Split-Course Radiotherapy in Advanced Head and Neck Cancer. In: Rustum, Y., McGuire, J.J. (eds) The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. Advances in Experimental Medicine and Biology, vol 244. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-5607-3_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5607-3_30

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4684-5609-7

  • Online ISBN: 978-1-4684-5607-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics